Lapatinib Ditosylate - API
| Product Name |
Lapatinib Ditosylate - API
|
| Product Code |
DA-L196-a
|
| Chemical name |
Lapatinib Ditosylate
|
| Synonyms |
N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine bis(4-methylbenzenesulfonate); 4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-, 4-methylbenzenesulfonate (1:2); 4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-, bis(4-methylbenzenesulfonate);
|
| Impurity |
NA
|
| CAS Number |
388082-77-7
|
| Alternate CAS # |
NA
|
| Molecular form |
C43H42ClFN4O10S3
|
| Appearance |
Light Yellow to Yellow Solid
|
| Melting Point |
NA
|
| Mol. Weight |
925.46
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
aromatics,heterocycles,metabolites,impurities,pharmaceutical standards,intermediates,Fine Chemicals,sulphur and selenium compounds,enzyme activators,enzyme inhibitors
|
| Boiling Point |
NA
|
| Applications |
Lapatinib Ditosylate is a reversible dual inhibitor of ErbB1 and ErbB2 tyrosine kinases. Antineoplastic.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
